TelyRx Holdings Inc. has seen notable price movement this week, reflecting its recent financial performance.
This week, TelyRx Holdings Inc. (TELY.TO) experienced a price increase of 8.33%, closing at C$2.60. Despite this growth, the stock's year-to-date performance remains down by 25.71%. Investors are likely assessing the implications of the company's recent financial results as well as its operational changes.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$69.14M
52W high
$4.25
52W low
$2.00
1W change
+8.33%
Analyst Price Targets
Based on analyst covering TELY · as of Sep 17, 2026
Wall Street analysts forecast TELY stock price to rise 130.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+130.8% Upside
Current Price
C$2.60
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
60.6%
Annualized
90-Day Vol
88.9%
Annualized
Trend (90d)
+25.0%
Annualized drift
90d Mean
C$2.84
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.68 | C$2.17 – C$3.30 |
| 60 trading days | C$2.76 | C$2.05 – C$3.71 |
| 90 trading days | C$2.84 | C$1.98 – C$4.08 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: TelyRx's recent financial results show a significant increase in revenue year-over-year, which could be a positive indicator for future performance. However, the stock's volatility and current underperformance relative to its 52-week range may warrant cautious consideration from investors.
Stock Gains 8.33% This Week, Closes at C$2.60
With a market cap of C$69.14 million, TelyRx Holdings is operating at a loss with a profit margin of -19.4%, highlighting the challenges the company faces despite revenue growth.
Bull case
The company's recent financial results indicate a strong upward trend in revenue, with Q2 2026 revenue nearly tripling from the previous year. This growth, along with an increasing number of prescriptions filled, suggests a solid operational model that could attract further investment.
Bear case
Despite recent gains, TelyRx's stock has dropped significantly year-to-date, and its profit margin remains negative. The low trading volume compared to the 20-day average could signal a lack of investor confidence, potentially leading to further price instability.
Recent Price Action
TelyRx Holdings Inc. has closed at C$2.60, reflecting an 8.33% increase this week. The stock's positive movement comes after a series of financial reports indicating significant revenue growth. However, the stock remains down 25.71% year-to-date, suggesting that while the company is making strides, investor sentiment may still be cautious.
Company News & Catalysts
Advertisement
While no major news was reported this week, TelyRx's recent financial announcements have drawn attention. The company reported a revenue increase to C$22.7 million for Q2 2026, a significant jump from C$9.3 million in the same quarter last year. This growth in revenue and the increase in prescriptions filled could serve as catalysts for future stock performance.
Technical Picture
From a technical standpoint, TelyRx's stock price is currently above its 50-day moving average of C$2.50 by 4.2%, but below its 200-day moving average of C$2.67 by 2.7%. The stock has traded within a 52-week range of C$2.00 to C$4.25, indicating that it is currently at approximately 27% of its range. The trading volume this week was 300 shares, significantly lower than the 20-day average of 50,726 shares, suggesting lower investor activity.
Insider Activity
No insider activity has been reported for TelyRx Holdings Inc. this week, which may indicate stability in management and no immediate changes in ownership structure.
Conclusion
TelyRx Holdings Inc. closed at C$2.60, unchanged on the day. While the stock has shown positive movement this week, investors should consider the broader context of the company's financial performance and market conditions before making investment decisions.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
